Sogo Medical Co., Ltd. announced consolidated earnings results for the first quarter ended June 30, 2017. For the quarter, the group reported net sales of ¥33,191 million, operating income of ¥1,387 million, ordinary income of ¥1,332 million and profit attributable to owners of the parent of ¥807 million or ¥41.16 per share compared to net sales of ¥28,102 million, operating income of ¥1,125 million, ordinary income of ¥1,101 million and profit attributable to owners of the parent of ¥616 million or ¥41.16 per share reported in the same period last year. Income before income taxes was ¥1,332 million against ¥1,086 million reported last year.

The company provided earnings guidance for the interim and year ending March 31, 2018. For the interim, the group expected to report net sales of ¥64,899 million, operating income of ¥2,605 million, ordinary income of ¥2,608 million and profit attributable to owners of the parent of ¥1,434 million or ¥95.86 per share.

For the year, the group expected to report net sales of ¥135,566 million, operating income of ¥7,001 million, ordinary income of ¥7,016 million and profit attributable to owners of the parent of ¥4,029 million or ¥269.19 per share.